Form 4 for TXG 10x Genomics, Inc.
Accepted 2023-06-07 00:00:00 ET · period of report 2023-06-05 · accession 0001610717-23-000099 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-07 | 2023-06-05 | TXG | STUELPNAGEL JOHN R | Dir | S - Sale | $54.89 | -10.0K | 333.7K | -3% | -$548.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-06-05 | S | D | 10,000 | $54.89 | 333,736 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $54.47 to $55.17. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |